PanGen Biotech Inc. | |
Stock Exchange | Korea Exchange |
EPS |
KRW665 |
Market Cap |
KRW160.54 B |
Shares Outstanding |
9.64 M |
Public Float |
6.05 M |
Address |
4/F, YeongtongInnoplex II Suwon GY 16675 Korea, Republic Of |
Employees | - |
Website | http://www.pangen.com |
Updated | 09/14/2018 |
PanGen Biotech, Inc. engages in the development of biopharmaceutical products. Its products include biosimilar erythropoietin, factor VIII and biosimilar G-CSF. The company was founded on January 29, 2010 and is headquartered in Suwon, South Korea. |